Talib Ahmed Karim, Sato Nobuyuki, Myojo Takuya, Sugiyama Eitaro, Nakagawa Naoki, Sakamoto Naka, Tanabe Yasuko, Fujino Takayuki, Takeuchi Toshiharu, Akasaka Kazumi, Matsuhashi Hironobu, Saijo Yasuaki, Kawamura Yuichiro, Doi Atsushi, Hasebe Naoyuki
Department of Cardiology, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Department of Cardiology, Abashiri Kosei Hospital, Abashiri, Japan.
Heart Vessels. 2016 Dec;31(12):2035-2044. doi: 10.1007/s00380-016-0828-8. Epub 2016 Mar 11.
The pro-arrhythmic triggers in Brugada and early repolarization syndromes (BrS, ERS) have not been analyzed systematically except for case reports. We clinically investigated the circumstances which precede/predispose to arrhythmic events in these syndromes during long-term follow-up. A detailed history from the patients/witnesses was taken to investigate the antecedent events in the last few hours that preceded syncope/ventricular fibrillation (VF); medical records, ECG and blood test from the emergency room (ER) were reviewed. 19 patients that fulfilled the investigation criteria were followed up for 71 ± 49 months (34-190 months). Prior to the event (syncope/VF), the patients were partaking different activities in the following decreasing order; drinking alcoholic beverage, having meal, and getting up from sleep, exercise. 3 patients reported mental/physical stress prior to the event and 2 patients developed VF several days after starting oral steroid for treatment of bronchial asthma. In the ER, elevated J-wave amplitude (0.27 ± 0.15 mV) was found with 58 % of the patients having hypokalemia. After electrolyte correction and cessation of steroids, the following day plasma K (4.2 ± 0.3 mEq/L, P < 0.001) was significantly increased and J-wave amplitude (0.13 ± 0.1 mV, P < 0.001) was remarkably reduced. Three patients were kept on oral spironolactone/potassium supplements. During follow-up for 71 ± 49 (34-190) months, among 4 patients with VF recurrence, one patient developed VF after taking oral steroid. In ERS and BrS, hypokalemia and corticosteroid therapy add substantial pro-arrhythmic effects, but potentially treatable. Stopping steroid therapy and avoiding hypokalemia had excellent long-term outcome.
除病例报告外,尚未对 Brugada 综合征和早期复极综合征(BrS、ERS)中的致心律失常触发因素进行系统分析。我们在长期随访中对这些综合征中导致心律失常事件的情况进行了临床研究。向患者/目击者详细询问病史,以调查晕厥/室颤(VF)前最后几小时内的先行事件;查阅了急诊室(ER)的病历、心电图和血液检查结果。19 例符合研究标准的患者接受了 71±49 个月(34 - 190 个月)的随访。在事件(晕厥/VF)发生前,患者进行的不同活动按频率递减顺序为:饮用酒精饮料、进餐、睡醒起床、运动。3 例患者报告事件发生前有精神/身体应激,2 例患者在开始口服类固醇治疗支气管哮喘几天后发生室颤。在急诊室,发现 J 波振幅升高(0.27±0.15mV),58%的患者存在低钾血症。电解质纠正和停用类固醇后,次日血浆钾(4.2±0.3mEq/L,P<0.001)显著升高,J 波振幅(0.13±0.1mV,P<0.001)明显降低。3 例患者持续口服螺内酯/补钾。在 71±49(34 - 190)个月的随访中,4 例室颤复发患者中,1 例在服用口服类固醇后发生室颤。在 ERS 和 BrS 中,低钾血症和皮质类固醇治疗会增加显著的致心律失常作用,但可能是可治疗的。停用类固醇治疗并避免低钾血症可取得良好的长期效果。